This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pasteur Limited. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Maurice Harmon: Innovator in Reverse Transcriptase Detection
Introduction
Maurice Harmon is a notable inventor based in Tannersville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the detection of reverse transcriptase activity. His work is crucial for ensuring the safety of biological products, including viral vaccines.
Latest Patents
Maurice Harmon holds a patent for the invention titled "CoRT-PCR assay for the discrimination of endogenous reverse transcriptase activity in eukaryotic cell lines from infectious retrovirus contamination." This patent addresses the detection of reverse transcriptase enzymatic activity in eukaryotic cell lines. The method he developed allows for the differentiation between endogenous reverse transcriptase activity and exogenous infectious retrovirus, which is vital for the production of safe biological products.
Career Highlights
Harmon has worked with Aventis Pasteur Limited, where he has applied his expertise in biotechnology. His innovative approach has led to advancements in the safety protocols for viral vaccine production. His patent reflects his commitment to improving the reliability of biological products.
Collaborations
Throughout his career, Maurice Harmon has collaborated with notable colleagues, including Scott J Goebel and Jim Tartaglia. These partnerships have contributed to the development of his innovative methods and have enhanced the impact of his work in the field.
Conclusion
Maurice Harmon is a distinguished inventor whose work in reverse transcriptase detection has significant implications for biotechnology and vaccine safety. His contributions continue to influence the industry and promote advancements in biological product safety.